• No results found

[PDF] Top 20 FORMULATION, DEVELOPMENT AND EVALUATION OF FLOATING BILAYERED TABLETS OF VENLAFAXINE HCL

Has 10000 "FORMULATION, DEVELOPMENT AND EVALUATION OF FLOATING BILAYERED TABLETS OF VENLAFAXINE HCL" found on our website. Below are the top 20 most common "FORMULATION, DEVELOPMENT AND EVALUATION OF FLOATING BILAYERED TABLETS OF VENLAFAXINE HCL".

FORMULATION, DEVELOPMENT AND EVALUATION OF FLOATING BILAYERED TABLETS OF VENLAFAXINE HCL

FORMULATION, DEVELOPMENT AND EVALUATION OF FLOATING BILAYERED TABLETS OF VENLAFAXINE HCL

... the floating bilayered tablets of venlafaxine ...retentive floating drug delivery system containing venlafaxine Hcl in the form of tablets using polymers like HPMC ... See full document

10

Formulation Development and Evaluation of Venlafaxine HCL Buccal Patch

Formulation Development and Evaluation of Venlafaxine HCL Buccal Patch

... [8-10]. Venlafaxine HCL (VNLF) is an antidepressant of the serotonin-nor epinephrine reuptake inhibitor (SNRI) class first introduced by Wyeth in ...of Venlafaxine in order to reduce the first pass ... See full document

5

Formulation and Evaluation of Sustained release tablets of Venlafaxine HCl

Formulation and Evaluation of Sustained release tablets of Venlafaxine HCl

... the development of sustained drug delivery ...of venlafaxine HCl using carbopol as rate controlling polymer has been ...carbopol tablets of venlafaxine HCl can be efficiently ... See full document

5

 FORMULATION AND EVALUATION OF MUCOADHESIVE MICROSPHERES OF VENLAFAXINE HCL

 FORMULATION AND EVALUATION OF MUCOADHESIVE MICROSPHERES OF VENLAFAXINE HCL

... are made from the biodegradable polymers in sustained drug delivery. Recently, dosage forms that can precisely control the release rates and target drugs to a specific body site have made an enormous impact in the ... See full document

6

Design Formulation and Evaluation of Ranitidine HCl Gastro
Retentive Floating Tablets

Design Formulation and Evaluation of Ranitidine HCl Gastro Retentive Floating Tablets

... and development of Gastro Retentive Floating tablet formulations of ...optimized formulation followed Higuchi’s kinetics while the drug release mechanism was found to be Non-Fickian Diffusion, Zero ... See full document

11

FORMULATION DEVELOPMENT AND IN-VITRO  CHARACTERIZATION OF FLOATING TABLETS OF DILTIAZEM HCL

FORMULATION DEVELOPMENT AND IN-VITRO CHARACTERIZATION OF FLOATING TABLETS OF DILTIAZEM HCL

... as floating tablets. Gastric floating of diltiazem hydrochloride tablets results from effervescence produced by the reaction between sodium bicarbonate and hydrochloric acid in ...of ... See full document

7

 FORMULATION AND EVALUATION OF BILAYERED FLOATING TABLETS OF METFORMIN HYDROCHLORIDE

 FORMULATION AND EVALUATION OF BILAYERED FLOATING TABLETS OF METFORMIN HYDROCHLORIDE

... total floating time and drug release. Bilayered floating matrix tablet with immediate release layer give good floating and a controlled release pattern after initial immediate ...maximum ... See full document

10

FORMULATION AND EVALUATION OF BILAYERED FLOATING TABLET OF DILTIAZEM DRUG

FORMULATION AND EVALUATION OF BILAYERED FLOATING TABLET OF DILTIAZEM DRUG

... Bilayer floating tablet of Diltiazem HCl tablet was prepared by direct compression ...The Tablets Containing HPMC K15M polymer Showed The high degree of ...the floating formulations buoyant up ... See full document

5

FORMULATION, DEVELOPMENT AND EVALUATION OF GASTRORETENTIVE FLOATING TABLETS OF LAFUTIDINE

FORMULATION, DEVELOPMENT AND EVALUATION OF GASTRORETENTIVE FLOATING TABLETS OF LAFUTIDINE

... HCL solutions at 37 0 C. Tablet containing Bees wax and Carnuba wax(F7) showed good buoyancy with very short lag time and long floatation time of more than 12 hrs in 0.1 N HCL. In-Vitro release study is ... See full document

12

FORMULATION DEVELOPMENT AND EVALUATION OF DOXOPHYLLINE HYDROCHLORIDE FLOATING TABLETS

FORMULATION DEVELOPMENT AND EVALUATION OF DOXOPHYLLINE HYDROCHLORIDE FLOATING TABLETS

... obtain floating, the balance between swelling and wa- ter acceptance must be ...of floating tablets of F1 to F7 is shown in Table (4). Tablets containing Carbopol 934P (F3) showed less ... See full document

8

FORMULATION, EVALUATION AND RADIOGRAPHIC STUDY OF STOMACH SPECIFIC FLOATING TABLETS CONTAINING VENLAFAXINE HYDROCHLORIDE FOR TREATMENT OF DEPRESSION

FORMULATION, EVALUATION AND RADIOGRAPHIC STUDY OF STOMACH SPECIFIC FLOATING TABLETS CONTAINING VENLAFAXINE HYDROCHLORIDE FOR TREATMENT OF DEPRESSION

... . Venlafaxine hydrochloride, is a highly water soluble and structurally novel antidepressant for oral ...N HCl and it decreases with increasing pH over the physiological ...of venlafaxine ... See full document

8

Formulation and evaluation of gastroretentive floating tablets of venlafaxine hydrochloride

Formulation and evaluation of gastroretentive floating tablets of venlafaxine hydrochloride

... The release rate of Venlafaxine HCl floating tablets was determined using USP Type 2 Apparatus. The dissolution test was performed in triplicate, using 900ml of 0.1N HCl, at 37± 0.5˚C ... See full document

7

FORMULATION DEVELOPMENT AND EVALUATION OF FLOATING TABLETS CONTAINING NIZATIDINE

FORMULATION DEVELOPMENT AND EVALUATION OF FLOATING TABLETS CONTAINING NIZATIDINE

... In vitro dissolution studies were carried out as per USP procedure using 0.1 N HCl (pH 1.2) as dissolution medium at 75 rpm. The in-vitro release profiles of Nizatidine from various formulations are shown in ... See full document

6

Formulation and evaluation of bilayered gastro retentive floating tablets containing metformin HCl and glipizide

Formulation and evaluation of bilayered gastro retentive floating tablets containing metformin HCl and glipizide

... [8] Floating systems or hydrodynamically controlled systems are low-density systems that have sufficient buoyancy to float over the gastric contents and remain buoyant in the stomach without affecting the gastric ... See full document

 FORMULATION AND EVALUATION OF GASTRORETENTIVE FLOATING TABLETS OF VENLAFAXINE HCl

 FORMULATION AND EVALUATION OF GASTRORETENTIVE FLOATING TABLETS OF VENLAFAXINE HCl

... gastroretentive floating tablets of Venlafaxine hydrochloride thus increasing its gastric residence time as well as bioavailability and therapeutic ...efficacy. Venlafaxine HCl having a ... See full document

5

FORMULATION AND EVALUATION OF FLOATING BILAYERED TABLETS OF NAPROXEN AND SUMATRIPTAN

FORMULATION AND EVALUATION OF FLOATING BILAYERED TABLETS OF NAPROXEN AND SUMATRIPTAN

... 900ml 0f 0.1 HCl was placed in vessel and the USP apparatus –II (Paddle Method) was assembled. The medium was allowed to equilibrate to temp of 37°c + 0.5°c. Tablet was placed in the vessel and the vessel was ... See full document

56

Formulation and in Vitro Characterization of Ciprofloxacin HCL Floating Tablets

Formulation and in Vitro Characterization of Ciprofloxacin HCL Floating Tablets

... The formulation was conceived using taguchi ...the floating capacity of the delivery ...on floating properties. The residual floating force values of the different grades of HPMC were in the ... See full document

128

 FORMULATION AND EVALUATION OF IMMEDIATE RELEASE VENLAFAXINE HCL TABLETS: COMPARATIVE STUDY OF SUPER DISINTEGRANT AND DILUENTS

 FORMULATION AND EVALUATION OF IMMEDIATE RELEASE VENLAFAXINE HCL TABLETS: COMPARATIVE STUDY OF SUPER DISINTEGRANT AND DILUENTS

... Venlafaxine HCl, microcrystalline cellulose, superdisintegrants (sodium starch glycolate, croscarmellose and crospovidone) aerosil, aspartame, diluents (mannitol and spray dried lactose), were sifted ... See full document

6

Formulation and In Vitro Evaluation of Bilayer Floating Tablets of Metformin HCL and Sitagliptin Phosphate

Formulation and In Vitro Evaluation of Bilayer Floating Tablets of Metformin HCL and Sitagliptin Phosphate

... formulate floating tablets of metformin hydrochloride using an effervescent approach for gastroretentive drug delivery ...system. Floating tablets were prepared using directly compressible ... See full document

155

FORMULATION AND EVALUATION OF FLOATING CAPSULES OF  PROPRANOLOL HCl USING MODIFIED PULSINCAP TECHNIQUE

FORMULATION AND EVALUATION OF FLOATING CAPSULES OF PROPRANOLOL HCl USING MODIFIED PULSINCAP TECHNIQUE

... Estimation of free formaldehyde content: The limit for residual formaldehyde according to FDA is 0.002% and the formaldehyde exposed hard gelatin capsule bodies passed the chromotropic acid test as the value obtained is ... See full document

8

Show all 10000 documents...